Amgen Regeneron Position for GLP-1 Expansion
Demand for GLP-1 therapies is spreading beyond diabetes into obesity and sleep apnea, and the market is already pricing the next wave of entrants. Amg
Regeneron
Every Fin-node story mentioning Regeneron — 1 story, newest first.
Regeneron · 1 story